Ackley, Michael A.
Sage Therapeutics (United States)
2 papers on CoChat
Most cited papers
- Verified
Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABAA receptor positive allosteric modulator
Althaus, A. L., Ackley, M. A., Belfort, G. M., Gee, S. M., Dai, J., Nguyen, D. P., Kazdoba, T. M., Modgil, A., Davies, P. A., Moss, S. J., et al. (2020) · Neuropharmacology
Neuroscience and Neuropharmacology ResearchTreatment of Major Depression
Cited by 135
- Verified
Neuroactive Steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano-1 H -pyrazol-1′-yl)-19-nor-5β-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (γ-Aminobutyric Acid) A Receptor
Martinez Botella, G., Salituro, F. G., Harrison, B. L., Beresis, R. T., Bai, Z., Blanco, M.-J., Belfort, G. M., Dai, J., Loya, C. M., Ackley, M. A., et al. (2017) · Journal of Medicinal Chemistry
Neuroscience and Neuropharmacology ResearchHeterocyclic Compound Synthesis and Bioactivity
Cited by 129
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free